Clinical Trials Browser

Leukemia, Prolymphocytic × Dasatinib × Clear all

NCT00364286 2026-01-20

Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)

Phase 2 Completed

17 enrolled 5 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic